Atlas Trials

Novartis

714 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Novartis

RecordFirmDate
A Real-world Study to Assess the Characteristics and Long-term Effectiveness of Inclisiran in Chinese Adult Patients (NCT06595069)Novartis2024-04-30
Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain (NCT06632730)Novartis2023-07-05
A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis (NCT06395909)Novartis2023-04-23
Real-World Evaluation of Patient Characteristics and Treatment Patterns Among Patients With CML-CP Treated With Asciminib (NCT06516029)Novartis2023-04-21
Real-World Persistence and Adherence of Ofatumumab Compared to Self-Injectable and Oral DMTs in Patients With Multiple Sclerosis (NCT06644638)Novartis2023-02-15
Real World Patient Characteristics and Treatment Patterns From Crizanlizumab Use: Preliminary Analysis From Select Sickle Cell Centers (NCT06662825)Novartis2022-12-13
A Real-world Study to Assess the Use of Siponimod in Spain to Treat Patients With Secondary Progressive Multiple Sclerosis (NCT06588387)Novartis2022-11-03
Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies (NCT06526000)Novartis2022-10-11
Relapse-Free Survival With Adjuvant Dabrafenib/Trametinib Therapy in Patients With BRAF V600-mutated Stage III/IV Melanoma (NCT06557291)Novartis2022-10-04
A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial Hypercholesterolemia (NCT06507852)Novartis2022-10-03
Heart Failure Therapy and Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction (NCT06671314)Novartis2022-06-02
Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery Registry (NCT06662812)Novartis2021-10-06
Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization of Metastatic Melanoma Patients (NCT06369428)Novartis2021-06-23
A Real-world Study of Effectiveness and Safety in HR+/HER2- Breast Cancer Patients Treated With Ribociclib or Alpelisib (NCT06705504)Novartis2021-06-11
Characteristics, Adherence, and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying Therapies (NCT06459232)Novartis2020-11-19
Real-life Treatment Patterns With Cyclin-dependent Kinase Inhibitors in Advanced Breast Cancer in Portugal - REVEAL Study (NCT06463626)Novartis2020-04-06
Next →

Track Novartis automatically

Every clearance here is in the API, with alerts when new ones post.